Study: ASV better for central apnea patients

Wednesday, January 24, 2018

SAN DIEGO – Patients with central sleep apnea who switch from positive airway pressure to adaptive servo ventilation therapy may be more adherent to therapy, according to a ResMed-funded study published in the Journal of Clinical Sleep Medicine. The study analyzed anonymous, aggregated data from the devices of 198,890 telemonitored patients with treatment-emergent central sleep apnea who started on PAP therapy. Researchers found 62.7% of patients were adherent on therapy while still on PAP; and 76.6% were adherent after switching to ASV therapy. “JCSM’s publication is a significant call for clinicians to monitor sleep apnea patients for central apneas and prescribe the therapy that best fits their needs,” said Carlos M. Nunez, M.D., ResMed’s chief medical officer.